IRIS
MALCOVATI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.483
AS - Asia 6.147
EU - Europa 3.921
SA - Sud America 999
AF - Africa 192
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 15
Totale 18.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.303
CN - Cina 2.657
SG - Singapore 1.405
HK - Hong Kong 877
IE - Irlanda 870
BR - Brasile 776
VN - Vietnam 565
RU - Federazione Russa 446
UA - Ucraina 438
FI - Finlandia 428
DE - Germania 420
IT - Italia 374
FR - Francia 280
GB - Regno Unito 215
SE - Svezia 194
IN - India 127
CA - Canada 80
AR - Argentina 74
BD - Bangladesh 74
ZA - Sudafrica 67
MX - Messico 65
JP - Giappone 63
IQ - Iraq 55
NL - Olanda 48
TR - Turchia 46
AT - Austria 42
PK - Pakistan 33
PL - Polonia 33
EC - Ecuador 30
ES - Italia 30
CO - Colombia 29
VE - Venezuela 28
ID - Indonesia 27
UZ - Uzbekistan 25
BE - Belgio 24
SA - Arabia Saudita 23
KE - Kenya 20
CL - Cile 18
PH - Filippine 18
TN - Tunisia 18
IL - Israele 17
PY - Paraguay 17
AU - Australia 14
MY - Malesia 14
JO - Giordania 13
MA - Marocco 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
PE - Perù 12
CZ - Repubblica Ceca 11
EU - Europa 10
KR - Corea 10
LT - Lituania 10
DZ - Algeria 9
EG - Egitto 9
NP - Nepal 9
MU - Mauritius 8
NG - Nigeria 8
BO - Bolivia 7
CH - Svizzera 7
ET - Etiopia 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
CR - Costa Rica 6
PS - Palestinian Territory 6
RS - Serbia 6
AL - Albania 5
AO - Angola 5
DK - Danimarca 5
IR - Iran 5
NI - Nicaragua 5
PA - Panama 5
UY - Uruguay 5
AM - Armenia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GR - Grecia 4
GT - Guatemala 4
HU - Ungheria 4
JM - Giamaica 4
LV - Lettonia 4
RO - Romania 4
SN - Senegal 4
BG - Bulgaria 3
GH - Ghana 3
HN - Honduras 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CY - Cipro 2
GD - Grenada 2
GE - Georgia 2
LY - Libia 2
MN - Mongolia 2
MR - Mauritania 2
Totale 18.733
Salva come PNG Salva come JPEG
Città #
Chandler 911
Dublin 868
Hong Kong 867
San Jose 781
Singapore 721
Ashburn 683
Dallas 586
Jacksonville 584
Nanjing 524
Beijing 382
Boardman 376
Lauterbourg 211
Princeton 210
Ho Chi Minh City 200
Nanchang 197
Lawrence 196
Medford 187
Los Angeles 183
Wilmington 170
New York 163
Changsha 154
Hebei 145
Shenyang 138
Hanoi 136
Jiaxing 119
Buffalo 117
Helsinki 115
Milan 91
Redondo Beach 90
Tianjin 89
Ann Arbor 84
Hangzhou 80
Moscow 77
Shanghai 75
Munich 71
Pavia 66
São Paulo 64
The Dalles 59
Seattle 54
Tokyo 53
Nuremberg 49
Orem 43
Johannesburg 38
Woodbridge 38
Santa Clara 37
Chicago 35
Frankfurt am Main 35
Norwalk 35
Toronto 35
Turku 35
Warsaw 32
San Francisco 31
Haiphong 30
Washington 30
Belo Horizonte 29
Brooklyn 28
Da Nang 28
Chennai 27
Montreal 25
Brussels 24
London 24
Fairfield 22
Guangzhou 21
Verona 21
Denver 20
Jinan 20
Mexico City 20
Nairobi 20
Tashkent 20
Columbus 19
Rio de Janeiro 19
Amsterdam 18
Zhengzhou 18
Boston 17
Falls Church 17
Baghdad 16
Brasília 16
Poplar 16
Atlanta 15
Council Bluffs 15
Des Moines 15
Stockholm 15
Ankara 14
Kunming 14
Vienna 14
Bogotá 13
Istanbul 13
Amman 12
Falkenstein 12
Phoenix 12
Rome 12
Baku 11
Dearborn 11
Dhaka 11
Houston 11
Hải Dương 11
Redwood City 11
Thái Bình 11
Asunción 10
Bắc Ninh 10
Totale 12.158
Salva come PNG Salva come JPEG
Nome #
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 163
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 161
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 148
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 148
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 146
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 143
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 143
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 141
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 139
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 137
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 135
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 135
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 127
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 127
Classification and prognostic evaluation of myelodysplastic syndromes 126
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 125
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 124
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 122
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. 117
Clinical significance of somatic mutation in unexplained blood cytopenia 115
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 114
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 113
Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010. 113
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 113
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 110
Clinical and biological implications of driver mutations in myelodysplastic syndromes 110
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 110
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 107
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 107
Hematologic passport for athletes competing in endurance sports: a feasibility study. 106
Myelodysplastic syndromes: diagnosis and staging. 106
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 106
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 106
Relationship between clone metrics and clinical outcome in clonal cytopenia 104
Myelodysplastic syndromes--coping with ineffective hematopoiesis. 104
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 104
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. 104
Revised international prognostic scoring system for myelodysplastic syndromes 104
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 102
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 101
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. 101
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 101
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 101
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 100
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 100
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 99
Appreci8: A pipeline for precise variant calling integrating 8 tools 99
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 98
Pan-cancer analysis of whole genomes 98
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 97
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 97
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 97
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 97
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. 97
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms 97
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 96
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 96
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 96
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing 95
Somatic mutations of calreticulin in myeloproliferative neoplasms 95
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 95
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications 94
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. 93
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives 92
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 92
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 91
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 91
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 91
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease 91
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 90
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 89
Myelodysplastic/myeloproliferative disorders 89
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 89
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 89
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 89
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. 88
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 86
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms 86
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 86
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 86
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. 86
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 86
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 85
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 85
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 84
Splenectomy for treatment of immune thrombocytopenic purpura. 84
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 84
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING 84
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS 84
Genetic and clinical heterogeneity of ferroportin disease. 83
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. 83
Simian virus 40 and lymphoproliferative disorder. 82
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants 82
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 82
Cerebral vasoreactivity in Andeans and headache at sea level. 81
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 81
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet 81
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) 81
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. 81
Gene expression and risk of leukemic transformation in myelodysplasia 81
Totale 10.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 0 0 0 0 140 95 34
2021/2022917 15 4 15 15 34 34 12 42 57 34 143 512
2022/20232.553 272 138 20 234 248 264 2 165 1.050 25 96 39
2023/20241.160 85 199 58 78 113 327 29 69 10 23 78 91
2024/20253.174 75 286 106 84 72 195 203 228 653 170 366 736
2025/20267.362 544 693 909 919 866 320 1.612 343 644 512 0 0
Totale 19.246